Helen Bygrave
Overview
Explore the profile of Helen Bygrave including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Venter W, Gandhi M, Sokhela S, Sikwese K, Bygrave H, Gama L, et al.
Lancet HIV
. 2024 Aug;
11(10):e711-e716.
PMID: 39159655
Large randomised studies of new long-acting medications for the prevention and treatment of HIV have shown high effectiveness and acceptability. Although modelling studies indicate these agents could be fundamental in...
2.
Barber M, Gotham D, Bygrave H, Cepuch C
JAMA Netw Open
. 2024 Mar;
7(3):e243474.
PMID: 38536176
Importance: The burden of diabetes is growing worldwide. The costs associated with diabetes put substantial pressure on patients and health budgets, especially in low- and middle-income countries. The prices of...
3.
Grimsrud A, Wilkinson L, Delany-Moretlwe S, Ehrenkranz P, Green K, Murenga M, et al.
J Int AIDS Soc
. 2023 Jul;
26 Suppl 2:e26095.
PMID: 37439076
Introduction: Long-acting and extended delivery (LAED) regimens for HIV treatment and prevention offer unique benefits to expand uptake, effective use and adherence. To date, research has focused on basic and...
4.
Cohn J, Bygrave H, Roberts T, Khan T, Ojji D, Ordunez P
Glob Heart
. 2022 May;
17(1):28.
PMID: 35586744
Hypertension is the most important risk factor for cardiovascular diseases (CVDs), which are the leading global cause of death. Hypertension is under-diagnosed and under-treated in most low- and middle-income countries...
5.
Tisdale R, Cazabon D, Moran A, Rabkin M, Bygrave H, Cohn J
Glob Heart
. 2021 Oct;
16(1):59.
PMID: 34692383
Expanding hypertension services in low- and middle-income countries requires efficient and effective service delivery approaches that meet the needs and expectations of people living with hypertension within the resource constraints...
6.
Webster R, Murphy A, Bygrave H, Ansbro E, Grobbee D, Perel P
Glob Heart
. 2020 Sep;
15(1):57.
PMID: 32923350
- Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor.- A symposium was held bringing...
7.
Ndlovu Z, Burton R, Stewart R, Bygrave H, Roberts T, Fajardo E, et al.
Lancet HIV
. 2020 May;
7(7):e514-e520.
PMID: 32473102
Patients with advanced HIV disease have a high risk of mortality, mainly from tuberculosis and cryptococcal meningitis. The advanced HIV disease management package recommended by WHO, which includes diagnostics, therapeutics,...
8.
Bygrave H, Golob L, Wilkinson L, Roberts T, Grimsrud A
Curr Opin HIV AIDS
. 2020 May;
15(4):256-260.
PMID: 32398467
Purpose Of Review: Differentiated service delivery (DSD) for HIV provides an approach to scaling services that are client-centred and aims to address client challenges whilst reducing the burden on health...
9.
Ford N, Geng E, Ellman T, Orrell C, Ehrenkranz P, Sikazwe I, et al.
PLoS Med
. 2020 Feb;
17(2):e1003028.
PMID: 32059023
Nathan Ford and co-authors discuss global priorities in the provision of HIV prevention and treatment services.
10.
Ehrenkranz P, Baptiste S, Bygrave H, Ellman T, Doi N, Grimsrud A, et al.
PLoS Med
. 2019 May;
16(5):e1002820.
PMID: 31141516
In a Policy Forum, Peter Ehrenkranz and colleagues discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and middle-income countries.